ME SHAREHOLDER UPDATE: 23andMe Holding Co. is Under Investigation for Breaches of Fiduciary Duties; Current Shareholders are Urged to Contact BFA Law (Nasdaq:ME)
September 25, 2024 07:11 ET
|
Bleichmar Fonti & Auld
23andMe Holding Co. shareholders are encouraged to contact BFA Law about its investigation into the Board for breaches of fiduciary duties.
ABR SEPTEMBER 30 DEADLINE: Arbor Realty Trust, Inc. has been Sued for Securities Fraud; Contact BFA Law before September 30 Court Deadline (NYSE:ABR)
September 25, 2024 07:11 ET
|
Bleichmar Fonti & Auld
Arbor Realty Trust, Inc. investors that lost money on their investment are encouraged to contact BFA Law before September 30, 2024 legal deadline.
BEN SHAREHOLDER UPDATE: Franklin Resources, Inc. is Under Investigation for Securities Fraud; Contact BFA Law if You Lost Money on Your Investment (NYSE:BEN)
September 25, 2024 07:11 ET
|
Bleichmar Fonti & Auld
Franklin Resources, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.
MXL SHAREHOLDER UPDATE: MaxLinear, Inc. is Under Investigation for Securities Fraud; Contact BFA Law if You Lost Money on Your Investment (Nasdaq:MXL)
September 25, 2024 07:11 ET
|
Bleichmar Fonti & Auld
MaxLinear investors that lost money on their investment are encouraged to contact BFA Law about their rights.
$250+ Mn Live Streaming Markets - Global Industry Coverage Report 2023-2030
September 25, 2024 07:09 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Live Streaming Market - Global Industry Coverage, Geographic Coverage and By Company" report has been added to ResearchAndMarkets.com's offering.The...
FORD OCTOBER 7 DEADLINE: Ford Motor Company has been Sued for Securities Fraud; Contact BFA Law before October 7 Court Deadline (NYSE:F)
September 25, 2024 07:09 ET
|
Bleichmar Fonti & Auld
Ford Motor Company investors that lost money on their investment are encouraged to contact BFA Law before October 7, 2024 legal deadline.
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
September 25, 2024 07:08 ET
|
Oruka Therapeutics, Inc.
Half-life in non-human primates (NHP) of 30.3 days after subcutaneous (SQ) administration and 33.8 days after intravenous (IV) administration Equivalent potency to risankizumab with similar binding...
Man Group PLC : Form 8.3 - International Paper Company
September 25, 2024 07:07 ET
|
Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Peter Ambler Joins Pano AI as Vice President of Global Government Affairs, Aims to Accelerate Wildfire Mitigation Efforts
September 25, 2024 07:07 ET
|
Pano AI
Peter Ambler joins Pano AI as VP of Global Government Affairs, bringing decades of experience to accelerate wildfire mitigation efforts through technology.
Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts
September 25, 2024 07:07 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured approximately $400 million in orders in 2024 and 2025 associated with its...
- September 25, 2024 07:07 ET Peter Ambler Joins Pano AI as Vice President of Global Government Affairs, Aims to Accelerate Wildfire Mitigation Efforts
- September 25, 2024 07:01 ET Demonstration Plant Construction Update